Virtual Reality in End Stage Kidney Disease
Recruiting · NCT06356168 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Pennsylvania
View the official record on ClinicalTrials.gov →Interventions studied
Individual Virtual RealitySocial Virtual Reality
What this trial is about
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month
Exclusion criteria
- Acutely ill
- Active nausea
- Epilepsy
Where it is running
1 location listed across 1 US state.
- University of Pennsylvania - Philadelphia, Pennsylvania, United States